CN111437314A - 一种治疗痤疮粉刺的药膏及其制备方法 - Google Patents
一种治疗痤疮粉刺的药膏及其制备方法 Download PDFInfo
- Publication number
- CN111437314A CN111437314A CN202010376749.1A CN202010376749A CN111437314A CN 111437314 A CN111437314 A CN 111437314A CN 202010376749 A CN202010376749 A CN 202010376749A CN 111437314 A CN111437314 A CN 111437314A
- Authority
- CN
- China
- Prior art keywords
- parts
- ointment
- acne
- treating acne
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 44
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 37
- 239000002674 ointment Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 21
- 239000004863 Frankincense Substances 0.000 claims abstract description 15
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 12
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 11
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 10
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 10
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 10
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 9
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 8
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 8
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 8
- 229940116229 borneol Drugs 0.000 claims abstract description 8
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 8
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 8
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 7
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 7
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 244000080767 Areca catechu Species 0.000 claims abstract description 6
- 229940079593 drug Drugs 0.000 claims abstract description 6
- 238000000227 grinding Methods 0.000 claims abstract description 6
- 238000010298 pulverizing process Methods 0.000 claims abstract description 6
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 10
- 244000235603 Acacia catechu Species 0.000 claims description 6
- 241000717739 Boswellia sacra Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 238000007873 sieving Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 18
- 238000011282 treatment Methods 0.000 abstract description 12
- 210000003491 skin Anatomy 0.000 abstract description 6
- 210000003780 hair follicle Anatomy 0.000 abstract description 3
- 230000036541 health Effects 0.000 abstract description 2
- 231100000957 no side effect Toxicity 0.000 abstract description 2
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 2
- 230000000638 stimulation Effects 0.000 abstract description 2
- 208000002193 Pain Diseases 0.000 description 13
- 230000008961 swelling Effects 0.000 description 11
- 206010042674 Swelling Diseases 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 208000020154 Acnes Diseases 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000218691 Cupressaceae Species 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000034507 Haematemesis Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001061 forehead Anatomy 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 206010000242 Abortion threatened Diseases 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 208000005985 Threatened Abortion Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000002389 essential drug Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及医疗卫生领域,公开了一种治疗痤疮粉刺的药膏,由下述重量配比的原料药制备而成:黄连3‑6份,黄芩3‑6份,黄柏3‑6份,冰片3‑6份,乳香3‑6份,没药3‑6份,儿茶5‑8份,调和剂若干。制备方法包括以下步骤:粉碎研磨、高温混合。本发明对粉刺、痤疮有很好疗效,且对皮脂腺和毛囊有很好的修复作用。可以短时间内治疗痤疮、粉刺,而且对皮肤无任何刺激,用药量少,绿色环保,操作简单,无副作用,疗效显著。
Description
技术领域
本发明涉及医疗卫生领域,特别涉及一种治疗痤疮粉刺的药膏及其制备方法。
背景技术
粉刺,痤疮症是十分常见的疾患,病因主要是表征于全身各部分面部,尤其是脸颊,有不同程度的脓包,红肿,毛囊发炎的现象,影响患者的正常生活,使患者经常羞于见人,给生活和工作带来极大的不便等。为解决以上现有难题,本发明公开了一种治疗粉刺痤疮的药膏,疗效显著,无毒副作用。
发明内容
针对上述背景中的问题,本发明提供了一种治疗痤疮粉刺的药膏及其制备方法,其制作简单,疗效显著,无毒副作用。
一种治疗痤疮粉刺的药膏,由下述重量配比的原料药制备而成:黄连3-6份,黄芩3-6份,黄柏3-6份,冰片3-6份,乳香3-6份,没药3-6份,儿茶5-8份,调和剂若干。
作为优选的,所述调和剂为乳化剂。
作为优选的,制备方法包括以下步骤:
(1)粉碎研磨:将上述重量份的黄连、黄芩、黄柏、冰片、乳香、没药及儿茶分别粉碎研磨,过80目筛,并混合均匀制得药粉;
(2)高温混合:将上述药粉及调和剂加入高温容器中,不停搅拌,直至成为乳膏状,即可制得。
作为优选的,所述步骤(2)中的温度为50-60℃。
作为优选的,所述药膏的使用方法为外敷于患处,每日一次,每次0.05g。
本发明的有益效果为:
本发明对粉刺、痤疮有很好疗效,且对皮脂腺和毛囊有很好的修复作用。可以短时间内治疗痤疮、粉刺,而且对皮肤无任何刺激,用药量少,绿色环保,操作简单,无副作用,疗效显著。
具体实施方式
下面将结合实施例对本发明的实施方案进行详细描述,但是本领域技术人员将会理解,下列实施例仅用于说明本发明,而不视为限定本发明的范围,实施例中未注明具体技术或条件者,按照本领域内的文献所描述的技术或条件或者按照产品说明书进行。
本发明所选原料分别具有以下功效。
黄连:
味苦,性寒;归心、脾、胃、肝、胆、大肠经;清热燥湿,泻火解毒;主治湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,心悸不宁,血热吐衄,目赤,牙痛,消渴,痈肿疗疮;外治湿疹,湿疮。
黄芩:
清热燥湿,泻火解毒,止血,安胎。用于湿温、暑温胸闷呕恶,湿热痞满,泻痢,黄疸,肺热咳嗽,高热烦渴,血热吐衄,痈肿疮毒,胎动不安。主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。
黄柏:
黄柏的特性是苦、寒,归于肾和膀胱经,常常用来治疗下焦、肾和膀胱经的湿热以及阴虚的情况,功能主治是清热燥湿、泻火、解毒,在临床中常用来治疗下焦湿热和阴虚火旺的情况。
冰片:
冰片味辛、苦,微寒;归心、肝、肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮。
乳香:
中药乳香的性味辛、苦、温,归心、肝、脾经。乳香的功效主要有活血行气,止痛,消肿生肌。乳香的作用主要有:用于外伤科,跌打损伤,疮疡痈肿,本品既能活血,化瘀止痛,又能活血消痈,祛腐生肌,为外伤科要药。治疗疮疡肿痛初起,红肿热痛,清热解毒,凉血消肿;用于淤血阻滞诸痛症,如心腹瘀痛,症瘕积聚,以及风湿痹痛等。
没药:
中药没药性味苦,辛,平,归心、肝、脾经。没药的功效主要有活血止痛,消肿生肌。没药的功效主要有:用于外伤科跌打损伤,疮疡痈肿既能活血化瘀止痛,又能消痈,去腐生肌,为外伤科要药;用于淤血阻滞诸痛证,如心腹瘀痛,症瘕积聚以及风湿痹痛等,本品辛散温通,既能活血,行气止痛,又能化瘀生津趋避。
儿茶:
性味苦、涩,微寒;归肺、心经;活血止痛,止血生肌,收湿敛疮,清肺化痰;主治用于跌扑伤痛,外伤出血,吐血衄血,疮疡不敛,湿疹、湿疮,肺热咳嗽。
实施例一:
一种治疗痤疮的药膏,其特征在于,由下述重量配比的原料药制备而成:黄连4份,黄芩5份,黄柏5份,冰片4份,乳香5份,没药3份,儿茶5份,乳化剂若干。
制备方法包括以下步骤:
(1)粉碎研磨:将上述重量份的黄连、黄芩、黄柏、冰片、乳香、没药及儿茶分别粉碎研磨,过80目筛,并混合均匀制得药粉;
(2)高温混合:将上述药粉及调和剂加入50-60℃高温容器中,不停搅拌,直至成为乳膏状,即可制得。
使用方法:
外敷于患处,每日一次,每次0.05g,三天为一个疗程。
实施例二:
一种治疗粉刺的药膏,其特征在于,由下述重量配比的原料药制备而成:黄连5份,黄芩6份,黄柏4份,冰片6份,乳香5份,没药4份,儿茶3份,乳化剂若干。
制备方法包括以下步骤:
(3)粉碎研磨:将上述重量份的黄连、黄芩、黄柏、冰片、乳香、没药及儿茶分别粉碎研磨,过80目筛,并混合均匀制得药粉;
(4)高温混合:将上述药粉及调和剂加入50-60℃高温容器中,不停搅拌,直至成为乳膏状,即可制得。
使用方法:
外敷于患处,每日一次,每次0.05g,三天为一个疗程。
实施例三:
一种治疗青春痘的药膏,其特征在于,由下述重量配比的原料药制备而成:黄连3份,黄芩6份,黄柏6份,冰片3份,乳香3份,没药6份,儿茶6份,乳化剂若干。
制备方法包括以下步骤:
(5)粉碎研磨:将上述重量份的黄连、黄芩、黄柏、冰片、乳香、没药及儿茶分别粉碎研磨,过80目筛,并混合均匀制得药粉;
(6)高温混合:将上述药粉及调和剂加入50-60℃高温容器中,不停搅拌,直至成为乳膏状,即可制得。
使用方法:
外敷于患处,每日一次,每次0.05g,三天为一个疗程。
典型病例如下:
病例1:顾x,男,18岁,额头长满粉刺,多数隐于皮下,肉眼看到一部分,用手触摸可以感到很多的痘,持续两年左右时间,使用本发明制备的药膏,每日一次,每次0.05g,一个疗程后表层粉刺明显消失,三个疗程后,基本痊愈,且无复发。
病例2:田x,女,21岁,面部起粉刺、红色丘疹6个月,额部、双颊较多。诊断寻常性痤疮。服用本发明制备的药膏,每日一次,每次0.05g,一个疗程后丘疹减少;四个疗程后丘疹及粉刺全部消失,痤疮治愈。
病例3:王xx,女,16岁,额头、脸颊等长满了青春痘,持续一年半到两年时间,前期使用过较多祛痘产品,效果不明显且有的产品导致青春痘加剧,皮肤红肿;使用时本发明制备的药膏,每日一次,每次0.05g,第二天症状明显减轻,皮肤红肿改善,三个疗程后,青春痘基本消退,皮肤也没有红肿,且更加光滑细嫩,一年内无复发。
实验统计:
选取痤疮、粉刺和青春痘患者共100例,年龄15~25岁,其中;痤疮患者35例,含女性28例,男性7例;青春痘患者30例,含女性20例,男性10例;粉刺患者35例,含女性15例,男性20例。对此100例患者采取如下治疗方案:痤疮患者使用实施例一制备的药膏,粉刺患者使用实施例二制备的药膏,青春痘患者使用实施例三制备的药膏,每日一次,每次0.05g,三天为一个疗程,连续使用三个疗程。
疗效评价标准包括:
(1)治愈:临床症状完全消失,疼痛和不适感完全消失,恢复正常生活;
(2)有效:全部或主要症状明显消除,疼痛和不适感明显消失,但还会出现轻微的症状,只部分恢复正常生活;
(3)无效:症状无明显变化。
实验结果如下:
治愈 | 有效 | 无效 | 治愈率 | |
痤疮患者35例 | 20 | 10 | 5 | 85.7% |
粉刺患者30例 | 18 | 8 | 4 | 86.7% |
青春痘患者35例 | 22 | 12 | 1 | 97.1% |
通过以上实验可知,本发明对粉刺痤疮及青春痘有良好的效果,且操作简单,无副作用。
以上所述仅为本发明专利的较佳实施例而已,并不用以限制本发明专利,凡在本发明专利的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明专利的保护范围之内。
Claims (5)
1.一种治疗痤疮粉刺的药膏,其特征在于,由下述重量配比的原料药制备而成:黄连3-6份,黄芩3-6份,黄柏3-6份,冰片3-6份,乳香3-6份,没药3-6份,儿茶5-8份,调和剂若干。
2.根据权利要求1所述的一种治疗痤疮粉刺的药膏,其特征在于,所述调和剂为乳化剂。
3.根据权利要求1-2任一所述的一种治疗痤疮粉刺的药膏,其特征在于,制备方法包括以下步骤:
(1)粉碎研磨:将上述重量份的黄连、黄芩、黄柏、冰片、乳香、没药及儿茶分别粉碎研磨,过80目筛,并混合均匀制得药粉;
(2)高温混合:将上述药粉及调和剂加入高温容器中,不停搅拌,直至成为乳膏状,即可制得。
4.根据权利要求3所述的一种治疗痤疮粉刺的药膏及其制备方法,其特征在于,所述步骤(2)中的温度为50-60℃。
5.根据权利要求3所述的一种治疗痤疮粉刺的药膏及其制备方法,其特征在于:所述药膏的使用方法为外敷于患处,每日一次,每次0.05g。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010376749.1A CN111437314A (zh) | 2020-05-07 | 2020-05-07 | 一种治疗痤疮粉刺的药膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010376749.1A CN111437314A (zh) | 2020-05-07 | 2020-05-07 | 一种治疗痤疮粉刺的药膏及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111437314A true CN111437314A (zh) | 2020-07-24 |
Family
ID=71654911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010376749.1A Pending CN111437314A (zh) | 2020-05-07 | 2020-05-07 | 一种治疗痤疮粉刺的药膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111437314A (zh) |
-
2020
- 2020-05-07 CN CN202010376749.1A patent/CN111437314A/zh active Pending
Non-Patent Citations (3)
Title |
---|
李世文等: "《中成药新用途》", 31 January 2017, 河南科学技术出版社 * |
田玉娥等: "中药内服外敷结合红蓝光照射治疗寻常型痤疮56例疗效观察", 《新疆中医药》 * |
肖静秋等: "三黄凝胶对耳廓痤疮模型大鼠血清IFN-β和IL-6的影响", 《中国皮肤性病学杂志》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104667244B (zh) | 一种治疗原发性痛经的足浴组合物 | |
CN103656127A (zh) | 一种治疗牙周炎的中药 | |
CN102068576B (zh) | 痔疮膏 | |
CN105030620A (zh) | 一种保湿祛痘洗面奶及其制备方法 | |
CN113209238A (zh) | 治疗靶向药物引起的手足综合症的洗剂及其制备方法 | |
CN104491107A (zh) | 治疗烧伤的中药制剂及其制备方法 | |
CN105999105A (zh) | 一种治疗褥疮和糖尿病溃烂的中药组合物及其制备方法 | |
CN111437314A (zh) | 一种治疗痤疮粉刺的药膏及其制备方法 | |
CN107982387A (zh) | 一种治疗烫伤的中药组合物及其制备方法 | |
CN113181318A (zh) | 一种治疗痔疮的中药药膏及其制备方法 | |
CN106822300B (zh) | 一种祛痘美颜的中药制剂 | |
CN104958757A (zh) | 压疮膏及压疮膏的制备方法 | |
CN104398613A (zh) | 一种治疗痔疮的中药 | |
CN103550471A (zh) | 一种治疗痹痛的中药组合物 | |
CN104173543B (zh) | 一种治疗失禁性皮炎的中药组合物 | |
CN110448601B (zh) | 一种治疗偏头痛的中药组合物 | |
CN108686080A (zh) | 一种褥疮膏及其制备方法 | |
CN113384636B (zh) | 一种外用治疗婴幼儿儿童特应性皮炎的消炎止痒中药配方及使用方法 | |
CN109847020A (zh) | 一种用于妇科炎症、缩阴的中药组合物及其制备方法和应用 | |
CN110882270B (zh) | 一种含有硅基再生医学材料的药物组合物及其制备方法 | |
CN109758565B (zh) | 一种穴位敷贴外治脾胃虚寒型慢性胃炎的中药组合物及其应用 | |
CN110496199B (zh) | 一种治疗牛皮癣的药物及其制备方法 | |
CN101983681A (zh) | 一种治疗白带异常的药剂 | |
CN105435123A (zh) | 一种治疗褥疮的组合药物 | |
CN115414427A (zh) | 治疗慢性皮肤瘙痒症的中药组合物及其制备方法、用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200724 |
|
RJ01 | Rejection of invention patent application after publication |